Acquiring Company
Emmes
Acquired Company
VaxTRIALS
RockvilleBiotechnologyHealth CareScience And EngineeringArtificial IntelligenceGovernment And MilitaryBiotechnologyHealth CareDescription
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of VaxTRIALS. Headquartered in Panama City, Panama, VaxTRIALS' 160+ staff members manage and monitor vaccine clinical trial activities throughout Latin America.
Quick answer
Emmes is acquiring VaxTRIALS, announced October 5, 2023. Emmes is based in Rockville, Maryland, United States.
- How much did Emmes pay for VaxTRIALS?
- The deal value was not disclosed.
- What does Emmes do?
- Emmes, founded more than 45-years ago, is a global, full-service Clinical Research Organization (CRO) dedicated to the advancement of public health and biopharmaceutical innovation.
- Where are Emmes and VaxTRIALS based?
- Emmes is based in Rockville, Maryland, United States.
- Who are the decision-makers at Emmes?
- Fundz holds 1 contact at Emmes. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Science And Engineering and Government And Military
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Regeneron Completes Acquisition Of Decibel Therapeutics, Adding Promising Gene Therapy Programs For Hearing Loss (September 25, 2023)
- Abbott Completes Acquisition Of Bigfoot Biomedical (September 22, 2023)
- Abbott To Acquire Bigfoot Biomedical, Furthering Efforts To Develop Personalized, Connected Solutions For People With Diabetes (September 5, 2023)
- Versiti Acquires Indianapolis-Based Pearl Pathways (November 7, 2023)
- United Therapeutics To Acquire Miromatrix Medical (October 30, 2023)
- Lilly To Acquire Point Biopharma To Expand Oncology Capabilities Into Next-Generation Radioligand Therapies (October 3, 2023)
Who to call at Emmes, and when
When Emmes changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Emmes raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Emmes, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Emmes. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Emmes makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired VaxTRIALS?
VaxTRIALS was acquired by Emmes, based in Rockville. The deal was reported on October 5, 2023. Emmes, founded more than 45-years ago, is a global, full-service Clinical Research Organization (CRO) dedicated to the advancement of public health and biopharmaceutical innovation. Emmes is privately held and operates in Biotechnology.
When did Emmes acquire VaxTRIALS?
Emmes's acquisition of VaxTRIALS was reported on October 5, 2023. Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of VaxTRIALS. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does VaxTRIALS do?
A specialized Clinical Research Organization, VaxTRIALS provides innovative solutions in managing and monitoring vaccine clinical trial activities across Latin America. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.